In HPASMC from controls and PAH patients TNFα stimulation resulted in a significant (p < 0.05) increase in the recruitment of NF-κB p65 to the κB binding site on the IL-6 and IL-8 promotor regions by ChIP (Fig. 7). Here, TNF is linked to pulmonary arterial hypertension.